Business Segments · Goodwill, non-deductible

Diagnostic Products — Goodwill, non-deductible

Abbott Diagnostic Products — Goodwill, non-deductible increased by 313.9% to $14.90B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 325.7%, from $3.50B to $14.90B. Over 3 years (FY 2022 to FY 2025), Diagnostic Products — Goodwill, non-deductible shows relatively stable performance with a -0.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryCapital Allocation
SignalLower is better
VolatilityStable
First reportedQ3 2016
Last reportedQ1 2026
Rolls up toGoodwill

How to read this metric

High levels may indicate past aggressive acquisition strategies, while changes reflect impairment testing or new M&A activity.

Detailed definition

The portion of goodwill arising from acquisitions within the diagnostics segment that cannot be deducted for tax purpose...

Peer comparison

Standard accounting metric for companies with significant M&A history.

Metric ID: abt_segment_diagnostic_products_goodwill_non_deductible

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value3.8B3.8B3.7B3.7B3.6B3.5B3.6B3.5B3.5B3.5B3.6B3.5B3.5B3.6B3.5B3.5B3.6B3.6B3.6B14.9B
QoQ Change+0.0%-2.6%+0.0%-2.7%-2.8%+2.9%-2.8%+0.0%+0.0%+2.9%-2.8%+0.0%+2.9%-2.8%+0.0%+2.9%+0.0%+0.0%+313.9%
YoY Change-5.3%-7.9%-2.7%-5.4%-2.8%+0.0%+0.0%+0.0%+0.0%+2.9%-2.8%+0.0%+2.9%+0.0%+2.9%+325.7%
Range3.5B14.9B
CAGR+33.3%
Avg YoY Growth+19.2%
Median YoY Growth+0.0%
Current Streak5 quarters growth

Frequently Asked Questions

What is Abbott's diagnostic products — goodwill, non-deductible?
Abbott (ABT) reported diagnostic products — goodwill, non-deductible of $14.90B in Q1 2026.
How has Abbott's diagnostic products — goodwill, non-deductible changed year-over-year?
Abbott's diagnostic products — goodwill, non-deductible increased by 325.7% year-over-year, from $3.50B to $14.90B.
What is the long-term trend for Abbott's diagnostic products — goodwill, non-deductible?
Over 3 years (2022 to 2025), Abbott's diagnostic products — goodwill, non-deductible has grown at a -0.2% compound annual growth rate (CAGR), from $14.40B to $14.30B.
What does diagnostic products — goodwill, non-deductible mean?
Acquisition-related intangible value that does not offer tax deduction benefits.